Ladenburg Thalmann Financial Services’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$122K	Sell	2,672 -968	-27%	-$38.4K	﹤0.01%	2865
2019 Q3	$130K	Buy	3,640 +231	+7%	+$8.59K	﹤0.01%	2765
2019 Q2	$136K	Sell	3,409 -200	-6%	-$7.87K	﹤0.01%	2747
2019 Q1	$150K	Buy	3,609 +20	+0.6%	+$813	﹤0.01%	2608
2018 Q4	$132K	Buy	3,589 +78	+2%	+$3.33K	﹤0.01%	2557
2018 Q3	$171K	Buy	3,511 +500	+17%	+$23.7K	﹤0.01%	2433
2018 Q2	$126K	Hold	3,011	–	–	﹤0.01%	2609
2018 Q1	$126K	Sell	3,011 -909	-23%	-$39.6K	﹤0.01%	2609
2017 Q4	$171K	Sell	3,920 -290	-7%	-$12.3K	﹤0.01%	2325
2017 Q3	$179K	Buy	4,210 +484	+13%	+$20.5K	﹤0.01%	2199
2017 Q2	$160K	Buy	3,726 +1,202	+48%	+$50.7K	﹤0.01%	2184
2017 Q1	$106K	Buy	2,524 +637	+34%	+$26K	﹤0.01%	2367
2016 Q4	$74K	Sell	1,887 -1,422	-43%	-$57.9K	﹤0.01%	2551
2016 Q3	$147K	Sell	3,309 -119	-3%	-$5.4K	﹤0.01%	1969
2016 Q2	$143K	Buy	3,428 +144	+4%	+$6.1K	﹤0.01%	1901
2016 Q1	$133K	Sell	3,284 -230	-7%	-$9.74K	﹤0.01%	1880
2015 Q4	$180K	Buy	3,514 +424	+14%	+$21.6K	﹤0.01%	1658
2015 Q3	$145K	Buy	3,090 +232	+8%	+$14K	﹤0.01%	1724
2015 Q2	$178K	Sell	2,858 -2,146	-43%	-$134K	﹤0.01%	1691
2015 Q1	$309K	Buy	5,004 +1,218	+32%	+$72.2K	0.01%	1297
2014 Q4	$205K	Buy	3,786 +1,422	+60%	+$77.7K	﹤0.01%	1415
2014 Q3	$125K	Buy	2,364 +2	+0.1%	+$102	﹤0.01%	1477
2014 Q2	$123K	Hold	2,362	–	–	﹤0.01%	1468
2014 Q1	$111K	Buy	2,362 +598	+34%	+$28.2K	﹤0.01%	1449
2013 Q4	$78K	Buy	1,764 +8	+0.5%	+$333	﹤0.01%	1622
2013 Q3	$68K	Buy	1,756 +244	+16%	+$9.23K	﹤0.01%	1619
2013 Q2	$53K	Buy	+1,512	New	+$51K	﹤0.01%	1706

Other funds holding XPH

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Ladenburg Thalmann Financial Services's XPH Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 27% in Q4 2019, selling an estimated $38.4K and leaving 2,672 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #2865.

Ladenburg Thalmann Financial Services first reported a position in XPH in Q2 2013 and has held it in 27 quarters since. The position peaked at $309K in Q1 2015. 75 funds tracked by Wall St. Rank hold XPH as of Q4 2019.

Ladenburg Thalmann Financial Services held 2,672 shares of State Street SPDR S&P Pharmaceuticals ETF worth $122K as of Q4 2019.
Ladenburg Thalmann Financial Services sold 968 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2019, an estimated $38.4K.
State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #2865 holding.
Ladenburg Thalmann Financial Services first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and has held it in 27 quarters since.
Ladenburg Thalmann Financial Services's State Street SPDR S&P Pharmaceuticals ETF position peaked at $309K in Q1 2015.
75 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.